共 78 条
[1]
Goodman C., The moving target problem and other lessons from percutaneous transluminal coronary angioplasty, pp. 123-140, (1996)
[2]
Windecker S., Maler-Rudolph W., Heyndrickx G., Et al., Interventional cardiology in Europe 1995, Eur Heart J, 20, pp. 484-495, (1999)
[3]
(2000)
[4]
Waters A.-M., Armstrong T., Senes-Ferrari S., (1998)
[5]
Aristides M., Gliksman M., Rajan N., Et al., Effectiveness and cost effectiveness of single bolus treatment with abciximab (ReoPro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients, Heart, 79, pp. 12-17, (1998)
[6]
Eccleston D.S., Eisenberg M.J., Funding of coronary angioplasty in public hospitals, Aust N Z J Med, 26, pp. 430-431, (1996)
[7]
Tu J.V., Pashos C.L., Naylor C.D., Et al., Use of cardial procedures and outcomes in elderly patients with myoacardial infarction in the United States and Canada, N Engl J Med, 336, pp. 1500-1505, (1997)
[8]
(1997)
[9]
Riviere M., Wang S., Leclerc C., Et al., Cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease in Canada, Can Med Assoc J, 156, pp. 991-997, (1997)
[10]
Zowall H., Coupal L., Fraser R.D., Et al., Economic impact of HIV infection and coronary heart disease in immigrants to Canada, Can Med Assoc J, 147, pp. 1163-1172, (1992)